Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 21 495 M
EBIT 2015 9 102 M
Net income 2015 1 086 M
Debt 2015 33 097 M
Yield 2015 -
Sales 2016 24 621 M
EBIT 2016 11 645 M
Net income 2016 3 809 M
Debt 2016 31 504 M
Yield 2016 -
PER 2015 47,10
PER 2016 26,36
EV / Sales 2015 7,04x
EV / Sales 2016 6,08x
Capitalization 118 310 M
More Financials
Company
Actavis plc operates as an investment holding company.It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products.The company operates through the following segments: North... 
Sector
Pharmaceuticals
Calendar
05/28 | 11:00amPresentation
More about the company
Surperformance© ratings of Actavis Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACTAVIS INC
05/21 CARL ICAHN : Carl Icahn says underweight Apple bets will hurt funds' performance
05/20 ACTAVIS : Reports Exceptional Performance in First Quarter 2015 with 59% Increas..
05/20 ACTAVIS : to Present at Bernstein's Thirty-First Annual Strategic Decisions Conf..
05/18DJDrug Deal to Generate Tax Benefits
05/17DJM&A Fuels Fundraising
05/16 PARATEK PHARMACEUTICALS : Reports First Quarter 2015 Financial and Operating Res..
05/15DJ
05/15DJGEORGE SOROS : Third Point Sells Entire $1 Billion Stake in Alibaba
More news
Sector news : Pharmaceuticals - NEC
04:08a RECKITT BENCKISER : Press release: CMA sets out provisional concerns over lubric..
04:06a MERCK KGAA : Leads European Research Consortium on Printed Electronics
02:52aDJRECKITT BENCKISER : Personal Lubricants Buy May Lessen Competition -UK Regulator
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF